TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 3 | 7 | 19 | 7 | 1 | -9 | 5 |
| P | %wins | 100 | 50 | 100 | 100 | 50 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/10/04 15:36 | 3/9/04 | VRX | Valeant Pharmaceuticals International | DE | Health | Drug | Pharmaceutical Preparations | Lamon Kim David | CA | O | P,Chief | P | 64 | 25.62 | 33 | 3 | 100 | 5 | I | -63 | -55 | -58 | -5 | -31 | -19 | -17 | -7 | 1 | -2 | 5 | 7 | -4 | -7 |
12/5/03 14:33 | 12/4/03 | VRX | Valeant Pharmaceuticals International | DE | Health | Drug | Pharmaceutical Preparations | Lamon Kim David | O | P,Chief | P | 62 | 24.91 | 33 | 3 | New | 3 | I | -70 | -50 | -66 | -57 | -37 | -30 | -9 | -8 | 5 | 15 | 33 | 7 | 6 | -10 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |